Institutional Manager · CIK 0001727492
Caligan Partners LP
New York, NY · File #028-23096
Latest AUM
$1.21B
Positions
24
Top-10 Concentration
84.2%
Filings
13
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORTQ/E Dec 202524 pos · $1.21B
- 13F HOLDINGS REPORTQ/E Sep 202518 pos · $763.5M
- 13F HOLDINGS REPORTQ/E Jun 202517 pos · $520.2M
- 13F HOLDINGS REPORTQ/E Mar 202516 pos · $479.2M
- 13F HOLDINGS REPORTQ/E Dec 202414 pos · $394.9M
- 13F HOLDINGS REPORTQ/E Sep 202412 pos · $315.5M
- 13F HOLDINGS REPORTQ/E Jun 202413 pos · $428.0M
- 13F HOLDINGS REPORTQ/E Mar 202412 pos · $378.3M
- 13F HOLDINGS REPORTQ/E Dec 202313 pos · $217.8M
- 13F HOLDINGS REPORTQ/E Sep 202313 pos · $177.8M
- 13F HOLDINGS REPORT (Amended)Q/E Jun 202311 pos · $120.2M
- 13F HOLDINGS REPORTQ/E Jun 202311 pos · $143.4M
- 13F HOLDINGS REPORTQ/E Mar 202311 pos · $126.1M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | LIQUIDIA CORPORATION | LQDA | 8,118,892 | $280.0M | 23.05% |
| 2 | ABIVAX SA | AAVXF | 1,451,924 | $195.8M | 16.12% |
| 3 | REVOLUTION MEDICINES INC | RVMDW | 1,283,900 | $102.3M | 8.42% |
| 4 | MINERALYS THERAPEUTICS INC | MLYS | 2,772,654 | $100.6M | 8.28% |
| 5 | MINERALYS THERAPEUTICS INC | MLYS | 2,298,400 | $83.4M | 6.87% |
| 6 | VAXCYTE INC | PCVX | 1,704,815 | $78.7M | 6.48% |
| 7 | EXELIXIS INC | EXEL | 1,553,262 | $68.1M | 5.60% |
| 8 | ADMA BIOLOGICS INC | ADMA | 3,012,508 | $54.9M | 4.52% |
| 9 | TANGO THERAPEUTICS INC | TNGX | 3,729,895 | $33.0M | 2.72% |
| 10 | INHIBRX BIOSCIENCES INC | INBX | 323,565 | $25.6M | 2.10% |
| 11 | TYRA BIOSCIENCES INC | TYRA | 944,257 | $24.8M | 2.04% |
| 12 | XENON PHARMACEUTICALS INC | XENE | 549,700 | $24.6M | 2.03% |
| 13 | XENON PHARMACEUTICALS INC | XENE | 549,665 | $24.6M | 2.03% |
| 14 | MAZE THERAPEUTICS INC | MAZE | 550,191 | $22.8M | 1.88% |
| 15 | RAPT THERAPEUTICS INC | 75382E208 | 644,400 | $21.8M | 1.80% |
| 16 | AVALO THERAPEUTICS INC | AVTX | 881,533 | $16.0M | 1.32% |
| 17 | ANIKA THERAPEUTICS INC | ANIK | 1,435,130 | $13.8M | 1.14% |
| 18 | INHIBRX BIOSCIENCES INC | INBX | 150,000 | $11.8M | 0.98% |
| 19 | VOR BIOPHARMA INC | VOR | 925,067 | $10.0M | 0.82% |
| 20 | INVENTIVA SA | IVEVF | 2,000,000 | $9.3M | 0.77% |